Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carolin Daniel

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
Nature Communications|March 16, 2016
Type 1 diabetes vaccine candidates promote human Foxp3(+)Treg induction in humanized miceIsabelle Serr, Rainer W Fürst, Peter Achenbach, et al.
Biorxiv : the Preprint Server for Biology|April 29, 2026
SATB1 is a targetable modulator of JAK-STAT signaling and cytokines in human Treg and Tconv cellsSaskia Kolb, Leonie Diekmann, Elizabeth D Lochert, et al.
Cardiovascular Research|June 23, 2019
Immunometabolism and atherosclerosis: perspectives and clinical significance: a position paper from the Working Group on Atherosclerosis and Vascular Biology of the European Society of CardiologyDaniel F J Ketelhuth, Esther Lutgens, Magnus Bäck, et al.
EMBO Reports|June 12, 2026
SATB1 is a targetable modulator of JAK-STAT signaling and cytokines in human Treg and Tconv cellsSaskia Kolb, Leonie Diekmann, Elizabeth E Lochert, et al.
Cancers|January 11, 2022
Aging Aggravates Cachexia in Tumor-Bearing MiceJulia Geppert, Alina A Walth, Raúl Terrón Expósito, et al.
Molecular Metabolism|January 15, 2026
Nuclear receptor co-factor TBL1X/TBL1XR1 T cell activity protects against atherosclerosisSahika Cingir Koker, Amit Mhamane, Julia Geppert, et al.
Molecular Metabolism|July 24, 2025
Inhibition of pyrimidine de novo synthesis fosters Treg cells and reduces diabetes development in models of Type 1 DiabetesHannah Hipp, Camilla Tondello, Hanna Gmehling, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 30, 2016
miRNA92a targets KLF2 and the phosphatase PTEN signaling to promote human T follicular helper precursors in T1D islet autoimmunityIsabelle Serr, Rainer W Fürst, Verena B Ott, et al.
Diabetes Care|January 21, 2026
Effect of High-Dose Oral Insulin in Children With Stage 1 Type 1 Diabetes: The Fr1da Insulin Intervention Randomized Controlled TrialAnette-Gabriele Ziegler, Ali Albeer, Stefanie Arnolds, et al.
Frontiers in Immunology|April 1, 2025
Nanoparticle platform preferentially targeting liver sinusoidal endothelial cells induces tolerance in CD4+ T cell-mediated disease modelsShu-Hung Wang, Isabelle Serr, Reinaldo Digigow, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Nature Communications|March 16, 2016
Type 1 diabetes vaccine candidates promote human Foxp3(+)Treg induction in humanized miceIsabelle Serr, Rainer W Fürst, Peter Achenbach, et al.
Biorxiv : the Preprint Server for Biology|April 29, 2026
SATB1 is a targetable modulator of JAK-STAT signaling and cytokines in human Treg and Tconv cellsSaskia Kolb, Leonie Diekmann, Elizabeth D Lochert, et al.
Cardiovascular Research|June 23, 2019
Immunometabolism and atherosclerosis: perspectives and clinical significance: a position paper from the Working Group on Atherosclerosis and Vascular Biology of the European Society of CardiologyDaniel F J Ketelhuth, Esther Lutgens, Magnus Bäck, et al.
EMBO Reports|June 12, 2026
SATB1 is a targetable modulator of JAK-STAT signaling and cytokines in human Treg and Tconv cellsSaskia Kolb, Leonie Diekmann, Elizabeth E Lochert, et al.
Cancers|January 11, 2022
Aging Aggravates Cachexia in Tumor-Bearing MiceJulia Geppert, Alina A Walth, Raúl Terrón Expósito, et al.
Molecular Metabolism|January 15, 2026
Nuclear receptor co-factor TBL1X/TBL1XR1 T cell activity protects against atherosclerosisSahika Cingir Koker, Amit Mhamane, Julia Geppert, et al.
Molecular Metabolism|July 24, 2025
Inhibition of pyrimidine de novo synthesis fosters Treg cells and reduces diabetes development in models of Type 1 DiabetesHannah Hipp, Camilla Tondello, Hanna Gmehling, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 30, 2016
miRNA92a targets KLF2 and the phosphatase PTEN signaling to promote human T follicular helper precursors in T1D islet autoimmunityIsabelle Serr, Rainer W Fürst, Verena B Ott, et al.
Diabetes Care|January 21, 2026
Effect of High-Dose Oral Insulin in Children With Stage 1 Type 1 Diabetes: The Fr1da Insulin Intervention Randomized Controlled TrialAnette-Gabriele Ziegler, Ali Albeer, Stefanie Arnolds, et al.
Frontiers in Immunology|April 1, 2025
Nanoparticle platform preferentially targeting liver sinusoidal endothelial cells induces tolerance in CD4+ T cell-mediated disease modelsShu-Hung Wang, Isabelle Serr, Reinaldo Digigow, et al.
Pageof 6